Shares of IOL Chemicals and Pharmaceuticals Ltd on Tuesday, November 11, reported a 56.3% year-on-year (YoY) growth in net profit to ₹30 crore for the second quarter that ended September 30, 2025. Net profit for the same quarter last year stood at ₹19.2 crore.
It reported ₹567.5 crore in revenue from operations, up 8% YoY and 2.8% sequentially. Revenue in the same quarter last year stood at ₹525.8 crore while in the June quarter IOL reported a revenue of ₹552 crore.
Earnings before interest, tax, depreciation and amortisation (EBITDA) grew by 37% from last year to ₹57 crore, while EBITDA margin improved by 210 basis points to 10% from 7.9% a year earlier.
In October, IOL Chemicals and Pharmaceuticals informed the exchanges that it had incorporated a wholly-owned subsidiary, IOL Pharmaxis UK Limited, in the United Kingdom. The company said the new entity was registered under the Companies Act, 2006 (England and Wales) on October 16, 2025.
Shares of IOL Chemicals and Pharmaceuticals Ltd ended 0.59% lower at ₹88.77 on the BSE today (November 11).
Also Read: Surya Roshni Q2: Net profit up 117%, revenue up 21%
First Published: Nov 11, 2025 5:23 PM IS
